Clinical Trial Update: Dose Escalation Study of TriN2755 in Advanced Solid Tumors and Sarcomas [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study investigating TriN2755 in patients with advanced solid tumors and sarcomas.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma
• Solid Tumor

Drugs mentioned

• TriN2755

Snippet

Sponsor: Trin Therapeutics GmbH | Conditions: Neoplasms | Phase 1 | Status: UNKNOWN